MT Genex Corporation (TYO:9820)

MT Genex Statistics

Total Valuation

MT Genex has a market cap or net worth of JPY 3.79 billion. The enterprise value is 1.69 billion.

Market Cap	3.79B
Enterprise Value	1.69B

Important Dates

The next estimated earnings date is Friday, February 6, 2026.

Earnings Date	Feb 6, 2026
Ex-Dividend Date	Mar 30, 2026

Share Statistics

MT Genex has 1.08 million shares outstanding.

Current Share Class	1.08M
Shares Outstanding	1.08M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	5.48%
Owned by Institutions (%)	2.42%
Float	283,666

Valuation Ratios

The trailing PE ratio is 14.70.

PE Ratio	14.70
Forward PE	n/a
PS Ratio	0.91
PB Ratio	0.91
P/TBV Ratio	0.93
P/FCF Ratio	12.44
P/OCF Ratio	11.57
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.49, with an EV/FCF ratio of 5.55.

EV / Earnings	6.57
EV / Sales	0.41
EV / EBITDA	3.49
EV / EBIT	4.23
EV / FCF	5.55

Financial Position

The company has a current ratio of 8.38, with a Debt / Equity ratio of 0.02.

Current Ratio	8.38
Quick Ratio	4.67
Debt / Equity	0.02
Debt / EBITDA	0.19
Debt / FCF	0.30
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 6.32% and return on invested capital (ROIC) is 5.97%.

Return on Equity (ROE)	6.32%
Return on Assets (ROA)	4.99%
Return on Invested Capital (ROIC)	5.97%
Return on Capital Employed (ROCE)	8.75%
Revenue Per Employee	31.16M
Profits Per Employee	1.93M
Employee Count	134
Asset Turnover	0.83
Inventory Turnover	n/a

Taxes

In the past 12 months, MT Genex has paid 163.00 million in taxes.

Income Tax	163.00M
Effective Tax Rate	38.72%

Stock Price Statistics

The stock price has increased by +37.00% in the last 52 weeks. The beta is 0.02, so MT Genex's price volatility has been lower than the market average.

Beta (5Y)	0.02
52-Week Price Change	+37.00%
50-Day Moving Average	3,477.60
200-Day Moving Average	3,118.54
Relative Strength Index (RSI)	55.08
Average Volume (20 Days)	1,015

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MT Genex had revenue of JPY 4.18 billion and earned 258.00 million in profits. Earnings per share was 239.78.

Revenue	4.18B
Gross Profit	1.02B
Operating Income	400.00M
Pretax Income	421.00M
Net Income	258.00M
EBITDA	486.00M
EBIT	400.00M
Earnings Per Share (EPS)	239.78

Balance Sheet

The company has 2.19 billion in cash and 92.00 million in debt, with a net cash position of 2.10 billion or 1,951.19 per share.

Cash & Cash Equivalents	2.19B
Total Debt	92.00M
Net Cash	2.10B
Net Cash Per Share	1,951.19
Equity (Book Value)	4.19B
Book Value Per Share	3,894.95
Working Capital	4.05B

Cash Flow

In the last 12 months, operating cash flow was 328.00 million and capital expenditures -23.00 million, giving a free cash flow of 305.00 million.

Operating Cash Flow	328.00M
Capital Expenditures	-23.00M
Free Cash Flow	305.00M
FCF Per Share	283.39

Margins

Gross margin is 24.34%, with operating and profit margins of 9.58% and 6.18%.

Gross Margin	24.34%
Operating Margin	9.58%
Pretax Margin	10.08%
Profit Margin	6.18%
EBITDA Margin	11.64%
EBIT Margin	9.58%
FCF Margin	7.31%

Dividends & Yields

This stock pays an annual dividend of 40.00, which amounts to a dividend yield of 1.15%.

Dividend Per Share	40.00
Dividend Yield	1.15%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	16.28%
Buyback Yield	n/a
Shareholder Yield	1.13%
Earnings Yield	6.80%
FCF Yield	8.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 27, 2017. It was a reverse split with a ratio of 0.1.

Last Split Date	Sep 27, 2017
Split Type	Reverse
Split Ratio	0.1

Scores

MT Genex has an Altman Z-Score of 4.8 and a Piotroski F-Score of 7.

Altman Z-Score	4.8
Piotroski F-Score	7